{
    "2018-12-03": [
        [
            {
                "time": "",
                "original_text": "虚惊一场！芬太尼管控趋严，14只概念股意外飘红",
                "features": {
                    "keywords": [
                        "芬太尼",
                        "管控",
                        "概念股",
                        "飘红"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "3家公司 的 3个仿制药通过或将通过一致性评价",
                "features": {
                    "keywords": [
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“母婴”新经济竞争激烈 “宝宝树”有何优势吸引阿里入股？",
                "features": {
                    "keywords": [
                        "母婴",
                        "宝宝树",
                        "阿里",
                        "入股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "互联网"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "我国多措并举保证药品供应 139种短缺药大部分复产供应",
                "features": {
                    "keywords": [
                        "药品供应",
                        "短缺药",
                        "复产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "11月，共有这些药企的品规通过一致性评价！",
                "features": {
                    "keywords": [
                        "药企",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "【医药】江琦、赵磊：2018年12月月报：正本清源、结构升级，把握创新、升级的确定性方向-20181202",
                "features": {
                    "keywords": [
                        "医药",
                        "正本清源",
                        "结构升级",
                        "创新",
                        "升级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "芬太尼成黑天鹅！14只A股5200亿市值或波及",
                "features": {
                    "keywords": [
                        "芬太尼",
                        "黑天鹅",
                        "A股",
                        "市值"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}